Taken together, these results support Jab1 as a direct downstream transcriptional target of MED1 in HER2+ breast tumors that can also reciprocally regulate MED1 ubiquitination and cyclic promoter recruitment (Figure 7K). This evidence concerns the gene COPS5 and breast neoplasm.